We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > orphan drugs

News List

Orphan drugs become the new favorite of pharmaceutical industry upon the huge market potential en-cphi.cn
April 07, 2017
FDA approved the marketing application of Merck Serono’s Avelumab through accelerated approval on March 23, 2017, which can be said to ignite the medical circle and again draws the public interest in words like “orphan drug” and “rare disease”.
ONCURIOUS Announces European Commission Confirmed Orphan Medicinal Product Designation for TB-403 fo firstwordpharma
January 18, 2017
ONCURIOUS NV announces that the European Commission has confirmed the orphan drug designation for TB-403 for medulloblastoma. Today's decision by the EC follows the earlier positive opinion issued by the European Medicine Agency (EMA).

Previous page 1 2 Next page